Wednesday September 12

	13.00			Welcome address, Jean-Olivier Defraigne, Vincent D’Orio
	\|			New insights in the aortic pathology
				Per Eriskon, Florence Pinet
	13.10			Insights from transcriptomic and proteomic analysis of human aneurysmal cells, Florence Pinet
	13.18			A mechanistic link between mechanical stress and inflammation in the progression of aortic diseases, Koichi Yoshimura
	13.26			Predicting AAA growth and rupture with a skin biopsy, Kakkhee Yeung
	13.34			A novel diagnostic score for AAA based on plasma D-dimer and myeloperoxidase, Wolf-Hans Eilenberg
	13.42			Functional implications and therapeutic relevance of neutrophil extracellular traps in AAA, Christine Brostjan
	13.50			Pathological remodeling of vascular smooth muscle in AAA: a therapeutic target? Marc Bailey
	13.58			Novel biomarkers of AAA derived from genetic and epigenetic studies, Gregory Jones
	14.06			Advanced glycation end products measured by skin autofluorescence are increased in patients with AAA, Clark J. Zeebregts
	14.14			Precision medicine in thoracic aortic disease, Julie De Backer
	14.22			Discussion

	\|			New insights from rodent models of aortic disease
				Marc Bailey, Lars Maegdefesse
	14.40			Critical review of the murine AAA models for 2018, Raphaël Coscas
	14.48			3D ultrasound imaging of murine AAA, Marc Bailey
	14.56			Anatomical modifications of the PPE model in mice, Albert Busch
	15.04			Lessons learnt from the Guinea pig rat transplantation model of AAA, Eric Allaire
	15.12			Therapeutic applications of prostaglandins and thromboxane A2 inhibitors in AAA, Audrey Courtois
	15.20			Molecular pathways driving aortic disease in mouse models of ACTA2, MYLK, and MYH11 mutations, Dianna Milewicz
	15.28			Discussion

	15.50			Coffee break

	\|			Imaging of aortic diseases
				Barry Doyle, Joy Roy
	16.20			Quantification of abdominal aortic calcification: inherent measurement errors in current computed tomography imaging, Clark J. Zeebregts
	16.28			The discrepancy between the non-automatic and semiautomatic measurement-does it influence outcome? Joy Roy
	16.36			Biomechanical wall stress and rupture potential in AAA – data from the MA3RS Trial, Barry Doyle
	16.44			Different AAA biomechanical rupture risk assessment approaches. Model fidelity versus diagnostic predictability, Christian Gasser
	16.52			Computational biomechanics and morphology of small rAAA – a report from the STAR database, Rebecka Hultgren
	17.00			IVUS and CO2 angiogram for aortic disease: strategy to minimize the use of contrast, Igor Sincos
	17.08			Discussion

	\|			Radiation exposure *
				Anders Wanhainen, Clark J. Zeebregts
	17.40			Strategies for optimal occupational radiation protection during vascular intervention, Bijan Modarai
	17.50			Effect of MRI on human lymphocyte DNA: myth or reality? Alain Nchimi
	18.00			Radiation protection in the endosuite and the importance of correct use of shields, Anders Wanhainen
	18.10			Short communication: back to basics, increasing the use of Postero anterior chest radiograph to aid assessment of chest pain for aortic dissection, Sacintha Perera
	18.14			Discussion

	18.30			End of the sessions


	BELGIAN ATTENDEES – Radiologists, cardiologists and vascular surgeons Thanks to our partnership with the AFCN (Agence Fédérale de Contrôle Nucléraire), the session on Radiation exposure* on Wednesday September 12 at 17.40 can be valued as 1hour of continuing education.